N1,N6-bis[(1S)-2-Methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(3-nitrophenyl)benzyloxy]-3,4-dihydroxyhexanediamide

InChIKey	`GNZIXCJETYMUQA-OYEZVYLDSA-N`
Compound Name	N1,N6-bis[(1S)-2-Methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(3-nitrophenyl)benzyloxy]-3,4-dihydroxyhexanediamide
Canonical SMILES	`CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(-c2cccc([N+](=O)[O-])c2)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(-c2cccc([N+](=O)[O-])c2)cc1)C(=O)N[C@H](C(=O)NC)C(C)C)C(C)C`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	8.85
Source	BindingDB;ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P03367	gag-pol	Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)	Pathogen	PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098	8.8	Ki	BindingDB
Q72874	pol	Human immunodeficiency virus type 1	Pathogen	PF00077	8.8	Ki	ChEMBL